Form 8-K - Current report:
SEC Accession No. 0001140361-21-016863
Filing Date
2021-05-11
Accepted
2021-05-11 17:25:51
Documents
6
Period of Report
2021-05-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10024430_8k.htm 8-K 613210
2 EXHIBIT 10.1(A) brhc10024430_ex10-1a.htm EX-10.1(A) 7054
3 image00004.jpg GRAPHIC 43698
4 image00005.jpg GRAPHIC 23899
5 image00006.jpg GRAPHIC 16495
6 image11.jpg GRAPHIC 49674
  Complete submission text file 0001140361-21-016863.txt   806507
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11460 | Film No.: 21912586
SIC: 2834 Pharmaceutical Preparations